Recombinant factor VIIa for warfarin-associated intracranial bleeding

Journal of Clinical Anesthesia

Volumn 20, Issue 4, 2008, Pages 276-279

  Ilyas, Can ^a   Beyer, Ginine M ^a   Dutton, Richard P ^a   Scalea, Thomas M ^a   Hess, John R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Elderly; Factor VIIa; International normalization ratio; Prothrombin time; Trauma; Traumatic brain injury

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MORTALITY; OUTCOME ASSESSMENT; PLASMA TRANSFUSION; PRIORITY JOURNAL; PROTHROMBIN TIME; RETROSPECTIVE STUDY;

AGED; ANTICOAGULANTS; BLOOD COAGULATION; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR VIIA; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TIME FACTORS; WARFARIN;

EID: 46249125890     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2007.12.012     Document Type: Article

References (22)

1. Flaherty M.L., Kissela B., Woo D., et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 68 (2007) 116-121
2. Caird E., Ayekun J., Nolan C., Nagaria J., and Philips J. The impact of antithrombotic therapy on neurosurgical emergency referral load. Ir Med J 99 (2006) 206-208
3. Sam C., Massaro J.M., D'Agostino Sr. R.B., et al. Framingham Heart Study. Warfarin and aspirin use and the predictors of major bleeding complications in arterial fibrillation (the Framingham Heart Study). Am J Cardiol 94 (2004) 947-951
4. Kucher N., Castellanos L.R., Quiros R., Koo S., Fanikos J., and Goldhaber S.Z. Time trends in warfarin-associated hemorrhage. Am J Cardiol 94 (2004) 403-406
5. Punthakee X., Doobay J., and Anand S.S. Oral-anticoagulant-related intracerebral hemorrhage. Thromb Res 108 (2002) 31-36
6. Nicolini A., Ghirarduzzi A., Iorio A., Silingardi M., Malferrari G., and Baldi G. Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia. Haematologica 87 (2002) 948-956
7. Mina A.A., Bair H.A., Howells G.A., and Bendick P.J. Complications of preinjury warfarin use in the trauma patient. J Trauma 54 (2003) 842-847
8. Ivascu F.A., Howells G.A., Junn F.S., Bair H.A., Bendick P.J., and Janczyk R.J. Rapid warfarin reversal in anticoagulated patients with traumatic brain injury reduces hemorrhage progression and mortality. J Trauma 59 (2005) 1131-1137
9. Flibotte J.J., Hagan N., O'Donnell J., Greenberg S.M., and Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 63 (2004) 1059-1064
10. Lee S.B., Manno E.M., Layton K.F., and Wijdicks E.F. Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP. Neurology 67 (2006) 1272-1274
11. Ivascu F.A., Janczyk R.J., Junn F.S., Bair H.A., Bendick P.J., and Howells G.A. Treatment of trauma patients with intracranial hemorrhage on preinjury warfarin. J Trauma 61 (2006) 318-321
12. Goldstein J.N., Thomas S.H., Frontiero V., et al. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke 37 (2006) 151-155
13. Yasaka M., Sakata T., Minematsu K., and Naritomi H. Correction of INR by prothrombin complex concentrates and vitamin K in patients with warfarin related hemorrhagic complications. Thromb Res 108 (2002) 25-30
14. Huttner H.B., Shellinger P.D., Hartman M., et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke 37 (2006) 1465-1470
15. Brody D.L., Aiyagari V., Shackleford A.M., and Diringer M.N. The use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocrit Care 2 (2005) 263-267
16. Freeman W.D., Brott T.G., Barrett K.M., et al. Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 79 (2004) 1495-1500
17. Sørensen B., Johansen P., Nielsen G.L., Sørensen J.C., and Ingerslev J. Reversal of the International Normalized Ratio with recombinant factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis 14 (2003) 469-477
18. Lin J., Hanigan W.C., Tarantino M., and Wang J. The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J Neurosurg 98 (2003) 737-740
19. Veshchev I., Elran H., and Salame K. Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma. Med Sci Monit 8 (2002) CS98-CS100
20. Como J.J., Dutton R.P., Scalea T.M., Edelman B.B., and Hess J.R. Blood transfusion rates in the care of acute trauma. Transfusion 44 (2004) 809-813
21. Ansell J., Hirsh H., Poller L., Bussey H., and Jacobson A Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 3 Suppl (2004) 204S-233S
22. Thomas G.O., Dutton R.P., Hemlock B., et al. Thromboembolic complications associated with FVIIa administration. J Trauma 62 (2007) 564-569